← Evidence map

ReviewHepatology international2017

Sofosbuvir/velpatasvir: a pangenotypic drug to simplify HCV therapy.

Rebecca Lee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

19 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 27928718